Skip to main content
Premium Trial:

Request an Annual Quote

Indiana Protein Center Signs First Clients, Receives Grants

NEW YORK, Aug. 24 (GenomeWeb News) - The Indiana Centers for Applied Protein Sciences, a for-profit venture that provides contract proteomic technology validation and protein analysis services, said yesterday that it has signed its first round of client agreements and that it has received two grants.

 

According to INCAPS, it now has committed projects from Eli Lilly, Dow AgroSciences and the Indiana University School of Medicine and is in varying stages of project development with several clients, including PurdueUniversity; IndianaUniversity, Bloomington; and the Lilly, IndianaUniversity, and Purdue research alliance Inproteo.

 

The first grant, worth $2 million, is from the State of Indiana's 21st Century Research and Technology Fund to defray start-up costs. The second, worth $400,000, is from the Indiana Department of Commerce and will allow INCAPS to purchase scientific equipment.

 

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.